Sara S McCoy1, Christie M Bartels2, Ian J Saldanha3, Vatinee Y Bunya4, Esen K Akpek5, Matthew A Makara6, Alan N Baer7. 1. S.S. McCoy, MD, MS, C.M. Bartels, MD, MS, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; ssmccoy@medicine.wisc.edu. 2. S.S. McCoy, MD, MS, C.M. Bartels, MD, MS, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. 3. I.J. Saldanha, MBBS, MPH, PhD, Center for Evidence Synthesis in Health, Department of Health Services, Policy, and Practice and Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. 4. V.Y. Bunya, MD, MSCE, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania. 5. E.K. Akpek, MD, Department of Ophthalmology, Johns Hopkins University School of Medicine. 6. M.A. Makara, MPH, Sjögren's Foundation, Reston, Virginia. 7. A.N. Baer, MD, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
OBJECTIVE: To define the association between oral and systemic manifestations of Sjögren syndrome (SS) and quality of life (QOL). METHODS: We analyzed a cross-sectional survey conducted by the Sjögren's Foundation in 2016, with 2961 eligible responses. We defined oral symptom and sign exposures as parotid gland swelling, dry mouth, mouth ulcers/sores, oral candidiasis, trouble speaking, choking or dysphagia, sialolithiasis or gland infection, and dental caries. Systemic exposures included interstitial lung disease, purpura/petechiae/cryoglobulinemia, vasculitis, neuropathy, leukopenia, interstitial nephritis, renal tubular acidosis, autoimmune hepatitis, primary biliary cholangitis, or lymphoma. Outcomes included SS-specific QOL questions generated by SS experts and patients. RESULTS: Using multivariable regression models adjusted for age, sex, race, and employment, we observed that mouth ulcers or sores, trouble speaking, and dysphagia were associated with poor quality of life. The following oral aspects had the greatest effect on the following QOL areas: (1) mouth ulcers/sores on the challenge and burden of living with SS (OR 4.26, 95% CI 2.89-6.28); (2) trouble speaking on memory and concentration (OR 4.24, 95% CI 3.28-5.48); and (3) dysphagia on functional interference (OR 4.25, 95% CI 3.13-5.79). In contrast, systemic manifestations were associated with QOL to a lesser extent or not at all. CONCLUSION: Oral manifestations of SS, particularly mouth ulcers or sores, trouble speaking, and dysphagia, were strongly associated with worse QOL. Further study and targeted treatment of these oral manifestations provides the opportunity to improve quality of life in patients with SS.
OBJECTIVE: To define the association between oral and systemic manifestations of Sjögren syndrome (SS) and quality of life (QOL). METHODS: We analyzed a cross-sectional survey conducted by the Sjögren's Foundation in 2016, with 2961 eligible responses. We defined oral symptom and sign exposures as parotid gland swelling, dry mouth, mouth ulcers/sores, oral candidiasis, trouble speaking, choking or dysphagia, sialolithiasis or gland infection, and dental caries. Systemic exposures included interstitial lung disease, purpura/petechiae/cryoglobulinemia, vasculitis, neuropathy, leukopenia, interstitial nephritis, renal tubular acidosis, autoimmune hepatitis, primary biliary cholangitis, or lymphoma. Outcomes included SS-specific QOL questions generated by SS experts and patients. RESULTS: Using multivariable regression models adjusted for age, sex, race, and employment, we observed that mouth ulcers or sores, trouble speaking, and dysphagia were associated with poor quality of life. The following oral aspects had the greatest effect on the following QOL areas: (1) mouth ulcers/sores on the challenge and burden of living with SS (OR 4.26, 95% CI 2.89-6.28); (2) trouble speaking on memory and concentration (OR 4.24, 95% CI 3.28-5.48); and (3) dysphagia on functional interference (OR 4.25, 95% CI 3.13-5.79). In contrast, systemic manifestations were associated with QOL to a lesser extent or not at all. CONCLUSION: Oral manifestations of SS, particularly mouth ulcers or sores, trouble speaking, and dysphagia, were strongly associated with worse QOL. Further study and targeted treatment of these oral manifestations provides the opportunity to improve quality of life in patients with SS.
Authors: Philip C Fox; Simon J Bowman; Barbara Segal; Frederick B Vivino; Nandita Murukutla; Karen Choueiri; Sarika Ogale; Lachy McLean Journal: J Am Dent Assoc Date: 2008-12 Impact factor: 3.634
Authors: Kristine Tanner; Jenny L Pierce; Ray M Merrill; Karla L Miller; Katherine A Kendall; Nelson Roy Journal: Ann Otol Rhinol Laryngol Date: 2015-04-03 Impact factor: 1.547
Authors: Kristine Tanner; Nelson Roy; Ray M Merrill; Katherine Kendall; Karla L Miller; Daniel O Clegg; Amanda Heller; Daniel R Houtz; Mark Elstad Journal: Laryngoscope Date: 2013-05-14 Impact factor: 3.325
Authors: Marta Jaskólska; Magdalena Chylińska; Anna Masiak; Katarzyna Nowicka-Sauer; Mariusz Siemiński; Marcin Ziętkiewicz; Zenobia Czuszyńska; Zbigniew Zdrojewski Journal: Rheumatol Int Date: 2020-03-14 Impact factor: 2.631
Authors: Sara S McCoy; Miguel Woodham; Christie M Bartels; Ian J Saldanha; Vatinee Y Bunya; Noah Maerz; Esen K Akpek; Matthew A Makara; Alan N Baer Journal: Arthritis Rheumatol Date: 2022-08-03 Impact factor: 15.483